Thermo Fisher Scientific Announces Collaboration to Develop Advanced Analytical Workflows for Clinical Laboratories

Thermo Fisher Scientific Announces Collaboration to Develop Advanced Analytical Workflows for Clinical Laboratories SAN JOSE, Calif., Sept. 3, 2019 /PRNewswire/ — Thermo Fisher Scientific, the world leader in serving science, and Cedars-Sinai, a leading nonprofit academic healthcare organization, have entered into a collaboration to develop a pathway to precision medicine through the development of robust,... Read more

Agilent Collaborates on Groundbreaking Study of Performance-Enhancing Spinach Extract

Agilent Collaborates on Groundbreaking Study of Performance-Enhancing Spinach Extract Freie Universität Berlin uses company’s cutting-edge tools to examine effects of ecdysterone SANTA CLARA, Calif., September 3, 2019 Agilent Technologies Inc. (NYSE: A) today announced that its instruments and expertise contributed to a groundbreaking study commissioned by the World Anti-Doping Agency, or WADA. Researchers at Freie... Read more

Fluidigm and the Icahn School of Medicine at Mount Sinai Collaborate on Landmark Single-Cell Study of the Human Epigenome

Aug 27, 2019 Mount Sinai selects Fluidigm single-cell microfluidics systems to identify epigenetic changes from environmental agents in study funded by the U.S. Department of Defense SOUTH SAN FRANCISCO, Calif., Aug. 27, 2019 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that it has... Read more

Agilent Completes Acquisition of BioTek Instruments

Agilent Completes Acquisition of BioTek Instruments Builds on Multi-Year Growth Strategy in Critical Cell Analysis Technology SANTA CLARA, Calif., August 26, 2019 Agilent Technologies, Inc. (NYSE: A) today announced it has completed the acquisition of BioTek Instruments, a global leader in the design, manufacture and distribution of innovative life science instrumentation. The BioTek acquisition expands... Read more

Agilent Completes Acquisition of BioTek Instruments

Builds on Multi-Year Growth Strategy in Critical Cell Analysis Technology SANTA CLARA, Calif., August 26, 2019 Agilent Technologies, Inc. (NYSE: A) today announced it has completed the acquisition of BioTek Instruments, a global leader in the design, manufacture and distribution of innovative life science instrumentation. The BioTek acquisition expands Agilent’s growing presence and expertise in... Read more

Neogen licenses food safety data analytics platform from Corvium

CONTACT: Steve Quinlan, Vice President & CFO, 517/372-9200 LANSING, Mich., Aug. 19, 2019 ― Neogen Corporation (NASDAQ: NEOG) announced today that it has signed a development and licensing agreement with Corvium, Inc., that will allow Neogen’s customers exclusive access to an enhanced version of Corvium’s award-winning CONTROL-PRO™ food risk intelligence platform. To be marketed under the... Read more

NUS, Agilent, and NUH launch new translational R&D hub to boost clinical diagnostics

NUS, Agilent, and NUH launch new translational R&D hub to boost clinical diagnostics S$38 million research facility aims to be a premier, global, one-stop hub for research and translation to clinical testing through biochemical innovation and techniques Singapore, 19 August 2019 The National University of Singapore (NUS), Agilent Technologies, a global leader in life sciences,... Read more

Reforest the Tropics and New England Biolabs®, Inc. enter into agreement to plant 100 hectares of forest to offset carbon emissions

Mystic, CT and Ipswich, MA (August 15, 2019): Reforest The Tropics (RTT), a 501(c)(3) non-profit organization based in Mystic, Connecticut and New England Biolabs, Inc. (NEB®), a global leader in the production of reagents for the life science industry, announce that they have entered into an agreement to plant 100 hectares (247 acres) of new tropical... Read more

Bio-Techne and Cygnus Technologies Announce Partnership for 3G CHO-HCP Assay

AUGUST 13, 2019 MINNEAPOLIS and SOUTHPORT, N.C., Aug. 13, 2019 /PRNewswire/ — Bio-Techne Corporation and Cygnus Technologies, part of Maravai LifeSciences, announced today a strategic partnership for the quantification of Chinese hamster ovary host cell proteins (CHO-HCP) on the ProteinSimple™-branded Ella™ immunoassay platform. Under the terms of the agreement, Bio-Techne and Cygnus are introducing the... Read more